United Patients Group

FEBRUARY 7, 2023

Inflammation can lead to a wide range of diseases and conditions, including heart disease, arthritis and cancer. This article will cover some common uses for medical cannabis when treating inflammation or pain along with what other ingredients might be helpful in reducing symptoms related to these conditions!

Cannabinoids 115

Cannabinoids Chronic Pain Terpenes THC 115

Cannabis Law Report

SEPTEMBER 14, 2021

A lack of consumer trust, transparency and scientific rigor has hampered the CBD and cannabinoid industry from reaching its growth potential for far too long”. About Radicle Science. Radicle Science is a transformative healthtech B-corp offering the first ever path to natural product validation at scale.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

NOVEMBER 17, 2021

Launch of Zylem ™ 20:1 further expands ZYUS product offerings with new cannabinoid formulation. The launch of this formulation marks an important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Extraction 52

Canna Care Docs

OCTOBER 3, 2023

However, many of these pharmaceutical medications can just induce more unpleasant, debilitating effects on those who are ill. Depending on the type of terminal illness diagnosed by the doctor, there are numerous pharmaceutical and conventional medications provided for patients to treat the symptoms that come with a terminal illness.

Chronic Pain 105

Chronic Pain Clinical Trials Patients Cannabinoids 105

Cannabis Law Report

DECEMBER 1, 2021

Cannabis and Life Sciences Company Initiates Internal Study Comparing Anti-Inflammatory Properties of Candidate JUVA-019 When Combined With Cannabinoids Such as THC and CBD. who has an extensive background in pharmaceutical research and development. November 30, 2021 04:00 ET | Source: Juva Life Inc.

Cannabinoids 52

Cannabinoids Research and Development Pharmaceutical THC 52

Cannabis Law Report

JANUARY 10, 2022

Minor Cannabinoids Market Size, Share & Trends Analysis Report by Product (CBG, CBC, CBN, THCV, CBGA), by Application (Pain Management, Neurological Disorders), and Segment Forecasts, 2021-2028” report has been added to ResearchAndMarkets.com’s offering. minor cannabinoids market size is expected to reach USD 26.2

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Cannabis Law Report

FEBRUARY 1, 2022

New softgel capsule products further expand ZYUS’ medical cannabinoid offerings and provide patients a precise method for dosing. The launch of these two new softgel products marks another important milestone in ZYUS’ mission to elevate cannabinoids as a standard of care and leverage their transformational potential.

Cannabinoids 52

Cannabinoids Patients Research and Development Media 52

MMJ Recs

APRIL 1, 2024

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52

CBD Clinical Trials Chronic Pain Epilepsy 52

TheAnswerPage

MAY 20, 2022

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Cannabis Law Report

AUGUST 6, 2021

CBD, which is an abbreviation for Cannabidiol, is one of Cannabis’s primary components – one of its primary Cannabinoids. Cannabinoids are the naturally occurring compounds found in the Cannabis plant. There are over 480 different Cannabinoids in the Cannabis plant. It is non-psychoactive and has a multitude of health benefits.

CBD 105

CBD Wellness and Beauty Treatment Pharmaceutical 105

FloridaMarijuana.net

AUGUST 15, 2018

The endocannabinoid system consists of cannabinoid receptors all over the body. When the body is defensive against trauma, this system begins to fail, resulting in physical, mental and/or neurological conditions. This system enables a connection between body and mind, signaling to all other systems when something feels good or bad.

Chronic Pain 150

Chronic Pain Marijuana Patients Clinical Trials 150

TheAnswerPage

AUGUST 19, 2021

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

Cannabis Law Report

JANUARY 16, 2022

Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) previously approved a prescription medicine derived from cannabis in 2014 to treat muscle spasms and spasticity from multiple sclerosis. Sativex was developed by GW Pharmaceuticals, a maker of cannabinoid therapeutics based in Ireland.

Research and Development 98

Research and Development Pharmaceutical Epilepsy Medicine 98

TheAnswerPage

JUNE 14, 2021

Has any national drug administration approved a CBD-containing product for therapeutic use in conditions other than epilepsy? ” GW Pharmaceuticals website. ” GW Pharmaceuticals website. See the Answer.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

The Cannigma

MARCH 7, 2022

So much attention is placed upon THC and CBD that sometimes the less abundant cannabinoids are forgotten about or not appreciated fully. Yet cannabinol (CBN), the first cannabinoid ever discovered by modern scientists, is slowly making a comeback in the cannabis industry. . Common cannabinoids in cannabis.

THC 140

THC Sleep Clinical Trials Cannabinoids 140

United Patients Group

APRIL 18, 2023

Because they often combine it with other drugs like cocaine or heroin or even legal ‘prescribed’ pharmaceuticals–and those are far more dangerous than cannabis itself! Another example, Age, weight, current health condition, sensitivities and even drug to drug interactions should be addressed.

Research and Development 110

Research and Development Indica Treatment Conditions 110

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

United Patients Group

FEBRUARY 2, 2023

There are also other parts of the plant with different uses such as seeds which can be eaten like nuts; stems/leaves which can be cooked into tea; resins/oils which can be ingested thru various methods including capsules, tinctures & edibles; and finally extracts which come from isolating specific compounds found within whole plants.

Blood Pressure 104

Blood Pressure Sleep Chronic Pain Digestion 104

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

MJ Business Attorneys

JUNE 29, 2018

The FDA approved Epidiolex as a prescription drug to be used to treat two severe epileptic conditions, Lennox-Gastaut syndrome and Dravet syndrome. DEA, the DEA expressed in their brief that they do not wish to control cannabinoids, but rather only those cannabinoids derived from the flowers and resins of a cannabis plant above.3%

DEA 113

DEA CBD Pharmaceutical Research and Development 113

The Cannigma

JANUARY 21, 2021

CBG (cannabigerol) is by far one of the most important cannabinoids in the cannabis plant. It is often called “the mother of all cannabinoids,” and it holds potential as a treatment for conditions such as diabetes, ALS, and Huntington’s disease, although human studies are seriously lacking. CBG vs CBD.

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

Cannabis Law Report

AUGUST 11, 2021

(“Avicanna”), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. The Branded Products include Avicanna’s proprietary cannabinoid topical formulations developed through years of extensive research by Avicanna’s team of scientists.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

The Cannigma

MAY 13, 2022

CBDA is a less studied cannabinoid but it is beginning to gain attention for its potential medical uses for a variety of applications including pain, inflammation, cancer, and COVID-19. While other cannabinoids can also help with some of these issues, CBDA has shown special promise for some of the more debilitating conditions on the list.

Tincture 115

Tincture Cannabinoids Strains CBD 115

Cannabis Law Report

JUNE 29, 2022

With the interest in potential utility of cannabis to develop treatments for a variety of medical conditions and the continued issuance of cannabis patents, the number of cannabis patent proceedings is likely to increase as well. Patent 1 , which claims various liquid formulations of enriched extracts of plant cannabinoids.

Research and Development 52

Research and Development Extraction Pharmaceutical Trichome 52

PrestoDoctor

OCTOBER 13, 2023

Marinol, also known as Dronabinol, is a medication used to treat a variety of conditions, including nausea and vomiting caused by chemotherapy, loss of appetite and weight loss in people with HIV/AIDS, as well as chronic pain. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98

Cannabis Law Report

OCTOBER 26, 2021

Following this selection, Tilray will supply a variety of its pharmaceutical-grade medical cannabis products, including extracts and dried flower with different degrees of THC and CBD for patients with varying medical conditions.

Pharmaceutical 52

Pharmaceutical Research and Development Patients Access 52

Canna Care Docs

SEPTEMBER 18, 2020

To prepare for your appointment you will want to collect your medical records about the condition you wish to treat with medical cannabis. This can be as simple as taking a picture of a prescription bottle you have been given to treat your condition. What Conditions Qualify for Medical Marijuana Cards in Virginia?

Pharmaceutical 98

Pharmaceutical Conditions Patients Oil 98

SpeedWeed

AUGUST 1, 2021

announced on July 30 that the company’s CW Labs science division and Colorado State University’s (CSU) College of Agricultural Sciences have completed the first of three collaborative metabolomic hemp studies to decode the complex chemical profile of full spectrum hemp extracts—made from the company’s patented hemp cultivars. .

Hemp 52

Hemp Extraction Agriculture Strains 52

Cannabis Law Report

AUGUST 14, 2021

This partnership marks Mary AG’s first application of farm-level technology, taking its knowledge in automated systems and applying that expertise to a holistic, controlled growing condition that incorporates automated plant health assessment. Working with CBDer on potential non-China greenhouse projects.

Hemp 105

Hemp Supply Chain Cannabinoids Extraction 105

Cannabis Info

MARCH 2, 2019

Epilepsy is a neurological condition, that directly affects the nervous system and causes seizures in individuals who suffer from the condition. However, the most common attempt at treating the condition is through medication, many patients may need to take them for the rest of their life. WHAT EXACTLY IS EPILEPSY? CASE STUDY.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

FloridaMarijuana.net

JUNE 19, 2018

When family members are sick or suffering, its natural to seek relief for their conditions and ailments. Sometimes traditional veterinary pharmaceuticals may not always be effective for dogs and cats and the side-effects may interfere with a pet’s quality of life. When a pet is ill, it can feel like a member of the family is suffering.

Pets 186

Pets CBD Tincture Oil 186

Veriheal

DECEMBER 28, 2021

Apart from business leaders, many corporate and government institutions are funding the research and development of cannabinoids for medical applications,” reads an excerpt from the report. Raphael Mechoulam inspired a wave of investigation into the therapeutic properties of cannabis, as well as its derivatives and extracts. .

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Miss Marijuana

NOVEMBER 4, 2020

As a company that takes pride in their safety level, Matter produces quality, effective, and consistent products that can provide therapeutic relief to those suffering from chronic medical conditions. The brand’s growers are pharmaceutical experts who think of the user’s best needs every step of the way. Abx – AbsoluteXrracts.

Strains 98

Strains Concentrates Extraction Pharmaceutical 98

Cannabis Law Report

NOVEMBER 29, 2019

For instance, THC has shown the potential to help in the treatment of conditions like PTSD, depression, eating disorders, and epilepsy. When a person uses a THC oil pen ( vapingdaily gives more details) to ingest this cannabinoid, it can benefit them in different ways. However, cannabinoids use modulation. THC Oil Benefits.

Oil 104

Oil THC Cannabinoids Research and Development 104

Alchimia

NOVEMBER 9, 2021

It’s not unusual for people to think that cannabis is the only plant that produces cannabinoids (after all, it has “canna” in its name). Medical cannabis has been used since ancient times; however, we finally know why this plant is so effective in treating several conditions. Echinacea: boost your immune system.

Cannabinoids 97

Cannabinoids Pets Research and Development Blood Pressure 97

The Cannigma

OCTOBER 9, 2021

Studies demonstrate that cannabis and its cannabinoid constituents have an implication on human urinary function. The common understanding is that every individual has a separate and different reaction to cannabinoid-based therapy, the same is true with how it might influence individual urinary symptoms.

Cannabinoids 86

Cannabinoids Consumption Patients Cannabis 86

The Cannigma

MAY 13, 2022

CBDA is a less studied cannabinoid but it is beginning to gain attention for its potential medical uses for a variety of applications including pain, inflammation, cancer, and COVID-19. While other cannabinoids can also help with some of these issues, CBDA has shown special promise for some of the more debilitating conditions on the list.

Tincture 69

Tincture Cannabinoids Strains CBD 69